Practical guide to sample size calculations: Non-inferiority and equivalence trials

Pharmaceutical Statistics

Volumn 15, Issue 1, 2016, Pages 80-89

  Flight, Laura ^a   Julious, Steven A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

clinical trials; equivalence; non inferiority; power; sample size

Indexed keywords

CALCULATION; SAMPLE SIZE; CLINICAL TRIAL (TOPIC); HUMAN; PROCEDURES; STATISTICS AND NUMERICAL DATA; THERAPEUTIC EQUIVALENCE;

CLINICAL TRIALS AS TOPIC; HUMANS; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY;

EID: 84954271587     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1716     Document Type: Article

References (15)

1. Flight LG, Julious SA,. Practical guide to sample size calculations: an Introduction. Pharmaceutical Statistics, DOI: 10.1002/pst.1709.
2. epiGenesys. A University of Sheffield company. Available at: https://www.epigenesys.org.uk/portfolio/sampsize// (accessed 07.07.2015).
3. CHMP. Guideline on the choice of non-inferiority margin. Doc CPMP/EWP/2158/99 January 2006. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003636.pdf (accessed 07.07.2015).
4. FDA Guidance for Industry,. Non-inferiority clinical trials (draft), 2010.
5. Julious SA,. Tutorial in Biostatistics: Sample sizes for clinical trials with Normal Data. Statistics in Medicine. 2004; 23: 1921-86.
6. Julious SA,. Sample sizes for clinical trials. Chapman and Hall: Boca Raton, Florida, 2009.
7. CPMP. Points to consider on switching between superiority and non-inferiority. (CPMP/EWP/482/99) 27 July 2000. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scien-tific-guideline/2009/09/WC500003658.pdf (accessed 07.07.2015).
8. ICH E10 Choice of control group in clinical trials. 2000. May 2001. Available at: http://www.ich.org/fileadmin/ Public\-Web\-Site/ICH-Products/Guidelines/Efficacy/E10/Step4/E10-Guideline.pdf (accessed 07.07.2015).
9. Jones B, Jarvis P, Lewis JA, Ebbutt AF,. Trials to assess equivalence: the importance of rigorous methods. British Medical Journal. 1996; 313: 36-39.
10. Julious SA,. The ABC of non-inferiority margin setting: an investigation of approaches. Pharmaceutical Statistics. 2011; 10 (5): 448-53.
11. Julious SA, Wang SJ, Issues with indirect comparisons in clinical trials particularly with respect to non-inferiority trials,. Drug Information Journal. 2008; 42 (6): 625-33.
12. ICH E9. Statistical principals for clinical trials. September 1998. Available at: http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E9/Step4/E9-Guideline.pdf (accessed 07.07.2015).
13. Bland JM, Altman DG,. One- and two-sided tests of significance. British Medical Journal. 1994; 309: 248.
14. Flight L, Julious SA,. Practical guide to sample size calculations: superiority trials. Pharmaceutical Statistics, DOI: 10.1002/pst.1718.
15. Morikawa T, Yoshida M,. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. Journal of Biopharmaceutical Statistics. 1995; 5 (3): 297-306.